A Phase IIb trial of PXT864 for Alzheimer's Disease
Latest Information Update: 28 Apr 2017
At a glance
- Drugs Acamprosate/baclofen (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- 26 Apr 2017 According to a Pharnext media release, this company expects to launch this trial in 2017.
- 04 Apr 2017 New trial record